Casdin Capital’s Exact Sciences EXAS Stock Holding History

Casdin Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90,000	Closed	-$4.92M	–	39
2025 Q3	$4.92M	Hold	90,000	–	–	0.41%	23
2025 Q2	$4.78M	Sell	90,000 -315,000	-78%	-$16M	0.44%	23
2025 Q1	$17.5M	Sell	405,000 -245,000	-38%	-$12.4M	1.43%	14
2024 Q4	$36.5M	Hold	650,000	–	–	2.43%	10
2024 Q3	$44.3M	Hold	650,000	–	–	2.95%	10
2024 Q2	$27.5M	Hold	650,000	–	–	2.1%	14
2024 Q1	$44.9M	Buy	650,000 +230,000	+55%	+$14.5M	3.34%	10
2023 Q4	$31.1M	Sell	420,000 -39,450	-9%	-$2.59M	3.05%	11
2023 Q3	$31.3M	Sell	459,450 -40,550	-8%	-$3.44M	3.47%	10
2023 Q2	$47M	Sell	500,000 -65,000	-12%	-$5.07M	4.1%	8
2023 Q1	$38.3M	Hold	565,000	–	–	3.16%	10
2022 Q4	$28M	Sell	565,000 -402,000	-42%	-$16.4M	2.17%	14
2022 Q3	$31.4M	Buy	967,000 +517,000	+115%	+$21.3M	2.06%	14
2022 Q2	$17.7M	Sell	450,000 -880,000	-66%	-$47.1M	1.5%	18
2022 Q1	$93M	Sell	1,330,000 -710,000	-35%	-$51.9M	4.17%	10
2021 Q4	$159M	Sell	2,040,000 -320,186	-14%	-$28.3M	4.48%	8
2021 Q3	$225M	Hold	2,360,186	–	–	5.61%	3
2021 Q2	$293M	Hold	2,360,186	–	–	7.45%	4
2021 Q1	$311M	Buy	2,360,186 +875,037	+59%	+$120M	9.26%	2
2020 Q4	$197M	Buy	+1,485,149	New	+$180M	5.83%	4
2016 Q4	–	Sell	-155,000	Closed	-$2.88M	–	26
2016 Q3	$2.88M	Buy	+155,000	New	+$2.73M	2.33%	15
2016 Q2	–	Sell	-60,000	Closed	-$404K	–	30
2016 Q1	$404K	Buy	+60,000	New	+$384K	0.46%	24

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Casdin Capital's EXAS Position: Q4 2025 in Review

Casdin Capital sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 90,000 shares — an estimated $4.92M sold.

Casdin Capital first reported a position in EXAS in Q1 2016 and held it in 22 quarters. The position peaked at $311M in Q1 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Casdin Capital reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Casdin Capital sold 90,000 Exact Sciences shares in Q4 2025, an estimated $4.92M.
Casdin Capital first reported a position in Exact Sciences in Q1 2016 and held it in 22 quarters.
Casdin Capital's Exact Sciences position peaked at $311M in Q1 2021.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Casdin Capital's 13F filing for Q4 2025, filed 17 Feb 2026.